Medical device companies and others in the healthcare sector stand to benefit from the tax reform Congress passed at the end of 2017, but the picture isn’t entirely rosy, according to a new report from S&P Global Ratings. In many ways, the report offers a corrective to the bullish statements coming from corporate CEOs such […]
Medtronic
Medtronic logs wins in overcharging lawsuit, defibrillator case fees
Medtronic (NYSE:MDT) logged a series of legal wins this week after a federal judge dismissed a whistleblower lawsuit against the medtech titan and the U.S. Supreme Court declined to review a bid over legal fees in a long-running patent spat, upholding Medtronic’s victory from April last year. In a lawsuit brought against Medtronic, Cavallino Consulting alleged […]
FDA clears Medtronic’s Riptide clot aspiration device
Medtronic (NYSE:MDT) said today that it won 510(k) clearance from the FDA for its Riptide clot aspiration device for treating ischemic stroke. The Riptide device is designed to retrieve blood clots via the Arc catheter to restore blood flow to the brain. The clearance covers patients with acute ischemic stroke secondary to intracranial large vessel occlusive disease […]
China dings Medtronic over Taiwan reference
Cyberspace regulators in China issued sharp criticism to Medtronic (NYSE:MDT) and other companies today for referring to Taiwan as an independent country on their websites, classifying it as “illegal content”. The medtech titan was told to make a public apology and remove the content. Ten minutes before a deadline set by Chinese regulators, Medtronic said in a statement […]
Medtronic touts therapy delivered via SynchroMed pump in patients with post-stroke spasticity
Medtronic (NYSE:MDT) touted data today showing that intrathecal baclofen therapy delivered via the company’s SychroMed II infusion pump performed better than the conventional treatment for patients with severe post-stroke spasticity. The medtech titan’s SynchroMed II pump is the only device approved in the U.S. for ITB therapy. Get the full story at our sister site, Drug […]
Svelte Medical launches pivotal trial for drug-eluting stent-on-a-wire
The first patient has been enrolled in Svelte Medical System‘s Optimize pivotal trial, which is designed to evaluate the safety and efficacy of Svelte’s drug-eluting stent integrated delivery system and rapid exchange platforms. The 2,000-person trial comes in the wake of a first-in-man trial for Svelte’s product and a study comparing the system with Medtronic‘s (NYSE:MDT) Resolute […]
FDA approves clinician app for Medtronic’s SynchroMed II drug pump
The FDA has approved a new clinician application for Medtronic‘s (NYSE:MDT) SynchroMed II intrathecal drug pump. The newly-approved programmer was designed to give doctors visual tools and improved workflows to simplify therapy management. The medtech titan’s implantable pump, which has been problematic in the past, delivers drugs directly to the fluid around the spinal cord. Get the full […]
Medtronic launches post-market SCS programming study
Medtronic (NYSE:MDT) said today it launched a post-market clinical study of its Evolve SM workflow spinal cord stimulation optimization program, having enrolled the first patient in the study. The first patient in the trial was enrolled at Wilmington, Del.’s Center for Interventional Pain & Spine, the company said. “Our goal is to improve or restore function. […]
Medtronic launches restructuring program looking to reduce costs by $3B by 2022
Medtronic (NYSE:MDT) yesterday announced the enterprise excellence program, a multi-year business growth and efficiency program focused on global operations, functional and commercial optimization looking to save $3 billion by the end of its 2022 fiscal year. The Fridley, Minn.-based company said that while it expects its overall employee base will remain relatively unchanged, there will be […]
The ‘smart pill’ market could be worth $3B by 2025 – meet the key players
The “smart pill” market is expected to nearly quadruple in value to $3 billion by 2025, according to Grand View Research. Driving this growth is an increasing demand for minimally-invasive procedures, as well as better patient monitoring capabilities. There are a number of players in the pharmaceutical and medtech arenas looking to stake a claim […]
Stroke treatment: There’s a simple way to improve it in the U.S.
Technology is already available to greatly improve outcomes for people suffering from strokes, but the present healthcare system is standing in the way of people getting it, according to Stacey Pugh, VP and general manager of the neurovascular unit at Medtronic. The most important thing that could boost stroke treatment is passing proper legislation about […]